Respirable bFGF ASO showed promise in preventing bleomycin-induced pulmonary fibrosis, likely through attenuating bFGF-mediated activation of the TGF-β1/Smad signaling mechanism in a rat model [67]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.